Misplaced Pages

This article's factual accuracy may be compromised due to out-of-date information. The reason given is: Per the 2021 update of the WHO classification, almost any oligoastrocytoma can be classified as either astrocytoma or oligodendroglioma via genetic testing. Oligoastrocytoma is reserved for tumors with incomplete diagnostics. Please help update this article to reflect recent events or newly available information. (August 2021)

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Oligoastrocytoma" – news · newspapers · books · scholar · JSTOR (May 2020) (Learn how and when to remove this message)

Oligoastrocytoma
A oligoastrocytoma on CT
Specialty	Neuro-oncology

Oligoastrocytomas are a subset of brain tumors that present with an appearance of mixed glial cell origin, astrocytoma and oligodendroglioma. However, the term "Oligoastrocytoma" is now considered obsolete by the National Comprehensive Cancer Network stating "the term should no longer be used as such morphologically ambiguous tumors can be reliably resolved into astrocytomas and oligodendrogliomas with molecular testing."

These types of glial cells that become cancerous are involved with insulating and regulating the activity of neuron cells in the central nervous system. Often called a "mixed glioma", about 2.3% of all reported brain tumors are diagnosed as oligoastrocytoma. The median age of diagnosis is 42.5. Oligoastrocytomas, like astrocytomas and oligodendrogliomas, can be divided into low-grade and anaplastic variant, the latter characterized by high cellularity, conspicuous cytologic atypism, mitotic activity and, in some cases, microvascular proliferation and necrosis.

However, lower grades can have less aggressive biology.

These are largely supratentorial tumors of adulthood that favor the frontal and temporal lobes.

Signs and symptoms

There are many possible symptoms of oligodendrogliomas that are similar to other gliomas. These symptoms may include headache, seizure and speech or motor changes.

Diagnosis

An X-ray computed tomography (CT) or magnetic resonance imaging (MRI) scan is necessary to characterize the anatomy of this tumor as to size, location, and its heter/homogeneity. However, final diagnosis of this tumor, like most tumors, relies on histopathologic examination (biopsy examination).

Treatment

If resected, the surgeon will remove as much of this tumor as possible, without disturbing eloquent regions of the brain (speech/motor cortex) and other critical brain structure. Thereafter, treatment may include chemotherapy and radiation therapy of doses and types ranging based upon the patient's needs. Subsequent MRI examination are often necessary to monitor the resection cavity.

Prognosis

Even after surgery, an oligoastrocytoma will often recur. The treatment for a recurring brain tumor may include surgical resection, chemotherapy and radiation therapy. Survival time of this brain tumor varies; younger age and low-grade initial diagnosis are factors in improved survival time.

References

1. Hiremath GK, Bingaman WE, Prayson RA, Nair D (September 2007). "Oligoastrocytoma presenting with intractable epilepsy". Epileptic Disord. 9 (3): 315–22. doi:10.1684/epd.2007.0117. PMID 17884756.
2. "NCCN Guidelines: Central Nervous System Cancers" (PDF). www.nccn.org. National Comprehensive Cancer Network. Retrieved 20 August 2018.
3. ^ "Oligodendroglioma". The Lecturio Medical Concept Library. Retrieved 21 August 2021.

External links

• Brain and Spinal Tumors: Hope Through Research from the U.S. (National Institute of Neurological Disorders and Stroke)

• Brain tumor